Discover How Synthetic Biology Companies Are Revolutionizing The Multi-Billion Dollar Consumer Packaged Goods Industry
If you’re a synthetic biology company looking to partner with leading companies, SynBioBeta’s Brands and Biology will help you craft a better story for your brand, and land that investment or partnership. If you're a brand, Brands and Biology is where you'll learn about the companies and developments in synthetic biology that will transform your business.
If You Don't Know What Consumer Biotech Is, You Will.
For the first-time ever, SynBioBeta is focusing on how synthetic biology is transforming the goods we use day-in, day-out: ingredients for cosmetics and cleaners, flavors and fragrances, fibers for fabrics, construction materials, leisure, and recreation.
Synthetic biology has the potential to reimagine entire industries, potentially impacting 40% of the global GDP, the equivalent of more than US$30 trillion.
Join us for two days of interactive, exceptional content delivered entirely online using the latest technology to keep the event entertaining, engaging, interactive - and above all, educational.
Come and hear about the latest technologies, learn how existing brands are leveraging synthetic biology to improve performance and sustainability, listen to startups tell you how they learned to create their brands, network with investors, and see new companies.
You only need to meet one person and take-away one idea to transform your business.
The 2-day interactive conference will consist of four in-depth and sixteen breakout sessions that will explore topics relevant to consumer brands and synthetic biology companies. Topics range from cellular agriculture, next generation beverages, fragrances and flavors, ingredients, sustainable fashion, and consumer brand building.
You will discover the impact that synthetic biology is having on consumer brands. Our experts will define the opportunities for synthetic biology to target consumers and the products they use. We will discuss how companies are engineering and brewing valuable, sustainable ingredients, how they’re changing the world of food and fashion, and how the accelerated technical developments in synthetic biology are reaching consumer markets.
You will discover the challenges faced by consumer brands adopting synthetic biology and synbio companies aiming to create brands to reach consumers. We’ll explore how materials will change when designed with biology; opportunities in cellular agriculture to feed the planet; and how synthetic biology is inherently sustainable. You will also be able to attend an investor panel, and explore this intriguing and essential topic from the perspectives of entrepreneurs and storytellers.
Hi, my name is John, and I am the founder of SynBioBeta.
I began my science career at NASA Ames, in the heart of Silicon Valley, seeking answers to how humans could live to visit the far reaches of our universe.
Today at SynBioBeta we help bio-entrepreneurs, companies, investors, researchers, visionaries, and thought leaders who are shaping the future of humanity to connect and bring projects to life.
Dopamine, disinformation, and the pursuit of science
A Leaps Talk with Tristan Harris on shaping human progress through biology
Tristan Harris is a design ethicist and critic of how the web is downgrading humanity. In this fireside chat with SynBioBeta founder John Cumbers, Harris will explore how the synthetic biology community ought to think about this digital moment in history. What happens when the technology of social media meets the biology of our minds? How does this color the public conversation around tackling global challenges like hunger, genetic disease, and climate change? Learn how tech and biology work for and against us in building a better world with biology.
FOLLOWED BY LIVE Q&A
Technology, culture, and forging audacious aims for our future
A Leaps Talk with George Church, DA Wallach & Kira Peikoff
In a time of COVID, climate-induced wildfires, and political division, how do we keep researchers and the public united to tackle humanity’s most pressing problems?? This conversation brings together a synthetic biology pioneer, an iconoclastic artist/entrepreneur, and a science journalist/bioethicist to explore the technological and cultural trends shaping biotechnology today. We’ll explore the most promising biotech tools for future-proofing humanity, how entrepreneurs and start-ups are catalyzing progress, and our obligations to one another in a shared vision for our biological future.
FOLLOWED BY LIVE Q&A
Meet the featured speakers of the Global Synthetic Biology Conference 2020
Co-founder, Director of Business Development
Gavin McIntyre co-founded Ecovative to solve environmental challenges through biology. He serves as Director of Business Development where he focuses on growing a network of international mycelium-material partnerships from small enterprises to large multinationals and government agencies.
CEO and Co-founder
Charles Dimmler is the co-founder and CEO of Checkerspot. His career has focused on building and leading teams at emerging growth companies in the life sciences and biotechnology sector. From 2008 to 2016, he served as Senior Vice President of Corporate Development at Solazyme
Jasmina is a cosmetics industry professional. Her previous company, Mother Dirt, included a line of products focused on the skin microbiome. Jasmina is working with Ginkgo to see what we can learn from nature and can harness through microbes for use for the brands of the future
J. Casey Lippmeier
VP of Innovation
Casey Lippmeier, PhD, is the VP of Innovation at Conagen, a leading biotech company delivering high-value ingredients to the food, nutritional, and pharmaceutical industries. Prior to joining Conagen, Casey was a principal scientist for DSM Nutritional Products, where he invented technologies for producing healthy fats, biodiesel and vaccines
Josh is a partner at Petri, a formation-stage venture capital firm focused on companies at the intersection of biology and engineering. Prior to Petri, Josh has worked with several early-stage startups in the sustainability and food & ag space
Creative Director and co-founder
Marti Romances is creative director and co-founder of Territory Studio. A motion graphic designer and multi-media artist, Marti articulates stories in captivating ways, drawing on his expertise of blending creativity with technology to realize compelling future-facing experiences
Co-founder & Director
Rachel came to the yeast industry while at graduate school at UC Berkeley, working to develop brewer’s yeast strains that produce hoppy flavors and aromas during fermentation. In 2017, Rachel co-founded Berkeley Yeast to engineer new yeasts for better and more sustainable fermented beverages
Will is co-founder and CEO of Culture Biosciences. Culture develops new bioprocessing technologies that make scaling bioprocesses faster and less risky. Culture currently works with a number of cellular agriculture companies
Chief Scientific Officer and Co-Founder
David leads technology innovation at Bolt Threads, creating and incubating biomaterials for improved consumer products. His obsession with biomaterials began with graduate research on silk during his Bioengineering PhD at UC Berkeley and UCSF. David has an orange belt in Krav Maga and is a great admirer of stencil graffiti
CEO and Founder
Jeffrey received his PhD from UC-Berkeley developing new methods to evolve microbes for improved product biosynthesis; subsequently, he co-founded Lygos, an industrial biochemicals company. As Revel’s CEO, Jeffrey now leads a team commercializing the world’s first caffeine alternative.
Erika M. Milczek
Founder & CEO
Erika is the Founder of Curie Co., a synthetic biology company that engineers clean, sustainable ingredients that extend product shelf-life. I’ve also attached a more complete bio if this one sentence is too light on information.
Ginger Krieg Dosier
President and CEO and Co-Founder
Ginger Krieg Dosier has multi-disciplinary business strategy experience managing a diverse team of scientists, engineers, architects, builders, funding partners, granting agencies, and strategic partners. Her primary background includes sustainable material development from prototype to commercialization, environmental architecture and design.
Partner and Managing Director
Boston Consulting Group
Co-Leader of the "Deep Tech Mission", BCG's unit focused on the deep tech approach to innovation, emerging technologies, and the new rules of engagement for all actors in the innovation space. Previously in charge of BCG’s Branding and Marketing.
Sarah is a scientist at CATALOG. She helped develop chemistry powering the Shannon DNA writer and data storage instrument to store the English text version of Wikipedia in DNA. Sarah has developed protocols for handling the milligram quantities of DNA and for retrieving data using sequencing.
CEO and Co-founder
Scott is the co-founder at Living Ink, where algae is transformed into pigments for inks and colorants for packaging and textile applications. Living Ink looks to nature for answers and is launching products in 2021 with some of the largest brands in the world.
co-founder and CEO
CEO of Cambium Biomaterials, designing and demonstrating previously unseen biomaterials for very high-performance applications in areas such as aerospace and space. Serial entrepreneur and VC creating new businesses at the intersection of biology, materials and tech
What Our Attendees Say About Us...
Come learn the latest technologies, hear the big announcements in the field, make new partnerships, meet investors, and discover new companies.
“SynBioBeta is the only synthetic biology conference that pays tribute to strong science and also strong business.”
Roche Venture Fund
“We made several valuable connections, including two potential investors, and a number of future customers.”
Founder, Bento Labs
“A conference not to be missed – this is the place for SynBioBeta power users, experts, key opinion leaders, investors, vendors, students and novices.”
CEO, Twist Bioscience
“SynBioBeta is uniquely focused on startups and entrepreneurs trying to change the world and the challenges we face to get to market.”
Our interactive breakout session will be 45 minutes and host up to 4 speakers. The SynBioBeta App brings you new and exciting ways of experiencing breakout sessions while interacting with speakers and conferees.
Get insights and unique perspective from some of today’s leading thinkers and practitioners on pushing the envelope of our field.
Our live Q&A will give you the opportunity to ask questions directly to our experts and learn from other attendees that will engage in the session.
Our live panel discussions feature leading experts in conversation about the big issues impacting our industry and the bioeconomy.
This interactive conference will give you insights and perspectives from leading global brands and the startups that are transforming the consumer packaged goods, fashion, foods, construction, and electronics industries with engineered biology. Biotechnology’s impact has long been underestimated due to the mistaken belief that biotech is a subset of the pharmaceutical industry. Everything from apparel to packaging is shifting from chemical-based manufacturing to biological processes.
AMONG THE TOPICS EXPLORED AT THE CONFERENCE ARE THE FOLLOWING:
What is consumer biotechnology and why does it matter now? What is a brand and how do we build one? How do we engage consumers with ingredients and products produced using the tools of biotechnology? Do consumers care about bio-tech derived ingredients? How are rare ingredients being “brewed” in the lab? How do those ingredients perform compared to “traditional” ingredients? How can we feed the growing population in the face of changing climate? What strategies are cellular agriculture companies adopting to make sure their products reach the shelves. Can synthetic biology be applied to fashion to make it more sustainable? How will the colors of fashion change when dyes are sustainable? How do we design performance into materials when we are able to start building at the atomic level? How can companies turn their waste streams into assets? Is that sustainable? What opportunities do investors seek in consumer biotech companies? How should consumer biotech companies engage the public to prevent another GMO backlash?